Stocksigma LogoStocksigma Logo

Welcure Drugs Board Meeting on 29th May'26 for Q4 and FY26 Results

Welcure Drugs & Pharmaceuticals has scheduled a Board of Directors meeting on 29th May'26. The agenda includes the consideration and approval of the

Welcure Drugs Board Meeting on 29th May'26 for Q4 and FY26 Results

Welcure Drugs & Pharmaceuticals Ltd 路 Intimation 路 29 May 2026, 5:30 am

Welcure Drugs Board Meeting on 29th May'26 for Q4 and FY26 Results Welcure Drugs & Pharmaceuticals has scheduled a Board of Directors meeting on 29th May'26. The agenda includes the consideration and approval of the audited financial results for the quarter and fiscal year ended 31st Mar'26. The board will also review and approve the audited financial statements, including the Balance Sheet, Statement of Profit and Loss, and Cash Flow Statement for the year. The statutory auditors' report on the financial results will also be taken on record.

Original exchange filing (PDF)

More announcements from Welcure Drugs & Pharmaceuticals Ltd

All Welcure Drugs & Pharmaceuticals Ltd announcements